FDA Device Recall Z-1538-2021
INNOVA MEDICAL GROUP, INC. · Pasadena, CA
Class I — life-threatening Ongoing
Device
For In Vitro Diagnostic Use Only *** 25T 888 SARS-CoV-2 Antigen *** SARS-CoV-2 Antigen Rapid Qualitative Test *** REF BT1309
Reason for recall
Due to distributing test kits to customers who were not part of a clinical investigation.
Recall record
- Recall number
Z-1538-2021- Classification
- Class I
- Status
- Ongoing
- Voluntary or mandated
- Voluntary: Firm initiated
- Firm notification
- Letter
- Distribution
- Worldwide distribution - U.S. Nationwide in the states of AL, AZ, CA, CO, CT, DC, DE, FL, GA, IL, IN, KY, MA, MD, ME, MI, MN, MO, NC, NE, NH, NJ, NV, NY, OH, PA, RI, TN, TX, UT, VA, VT, WA, and WI. The countries of Canada, India and United Kingdom.
- Recall initiated
- 2021-04-09
- Classified by FDA Center
- 2021-06-10
- FDA published
- 2021-06-16
- Recalling firm
- INNOVA MEDICAL GROUP, INC.
- Firm location
- Pasadena, CA
Operational response
A Class I device recall indicates a strong likelihood of serious adverse health consequence or death from continued use. Identify affected units by serial number, lot, or GTIN against your inventory and against implanted-device patient registry. Pull affected inventory from active use immediately. For implanted devices, follow the recalling firm’s patient-notification protocol; in most cases this requires informing affected patients and their treating physicians directly.
For the official FDA enforcement record, see FDA's Recall Search.